Mrv1909 12231921112D 19 20 0 0 0 0 999 V2000 -2.5006 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5006 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7860 0.8250 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 -3.2151 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7860 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2151 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7860 1.6500 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -3.9296 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7860 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.9296 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3571 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3573 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7862 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5007 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2151 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9296 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 1 4 2 0 0 0 0 2 5 1 0 0 0 0 2 6 2 0 0 0 0 3 7 2 0 0 0 0 3 8 1 0 0 0 0 4 9 1 0 0 0 0 5 10 2 0 0 0 0 5 11 1 0 0 0 0 6 12 1 0 0 0 0 7 13 1 0 0 0 0 7 10 1 0 0 0 0 9 12 2 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 18 19 1 0 0 0 0 M CHG 2 3 1 8 -1 M END > DB07918 > drugbank > CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1 > InChI=1S/C16H21NO2/c1-2-3-4-5-6-9-13-12-16(18)14-10-7-8-11-15(14)17(13)19/h7-8,10-12,18H,2-6,9H2,1H3 > NZPACTGCRWDXCJ-UHFFFAOYSA-N > C16H21NO2 > 259.3434 > 259.157228921 > 2 > 40 > -0.30195848665788394 > 30.492750301285003 > 1 > 1 > 0 > 1 > 2-heptyl-4-hydroxyquinolin-1-ium-1-olate > 2.56 > 3.8348030869999996 > -4.41 > 0 > 0 > 2 > 0 > 8.596152527275848 > 3.4906864323983307 > 47.17 > 77.9949 > 6 > 1 > 1.00e-02 g/l > darolutamide > 0 > DB07918 > experimental > 2-heptyl-4-hydroxyquinoline N-oxide > 2-(n-heptyl)-4-hydroxyquinoline N-oxide; 2-heptyl-4-hydroxyquinoline N-oxide; 2-heptyl-4-hydroxyquinoline-N-oxide; 2-heptyl-4-quinolinol 1-oxide; HOQNO; HQNO $$$$